chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pain in the back of his neck on the right side; it was like a stiff neck; This is a spontaneous report received from contactable consumer. The reporter is the patient.  An 81-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administered in the left arm, administration date 16Mar2021 10:00 (Lot number: EN6205) at the age of 81 years as dose 2, single for COVID-19 immunisation. The patient had no relevant medical history. The patient took concomitant medications. Vaccination history included: BNT162B2 (dose 1, administered in the left arm, Lot number: EL926F [the writing was hard to read]), administration date: 23Feb2021, when the patient was 81 years old, for COVID-19 immunisation. The following information was reported: NECK PAIN (non-serious) with onset 22Mar2021, outcome "unknown", described as "pain in the back of his neck on the right side"; MUSCULOSKELETAL STIFFNESS (non-serious) with onset 22Mar2021, outcome "unknown", described as "it was like a stiff neck". Therapeutic measures were taken as a result of neck pain, musculoskeletal stiffness.  Additional information: The patient took concomitant medications which included water pill and blood thinners, 2 pills. Therapeutic measures were taken as a result of neck pain, musculoskeletal stiffness. The patient has been putting heat on it and that it was better with heat.  No follow-up attempts are possible. No further information is expected.
pt recv vax & devel an inj site rxn characterized by redness, swelling & warmth;this is 1 of 7 of this facility to have an adverse exp p/vax lot# 4978167
Received flu shot in right thigh. Developed dizziness, lightheadedness 15 minutes after receiving shot. Swollen glands in neck. Not fully recovered at this time. Took 37.5 mg BENADRYL with some relief.
Headache, slight chills. Slight body ache.  Sleeplessness.
Approx 12 hrs after rec. PNEUMOVAX in (L) arm pt noticed swelling and pain in the injection site area. It got red and felt warm. Pt states she saw improvement 9/13/13 and was 90% better on 9/14/13.
Within a few hours of the 2nd injection, pt developed hives on her left arm. Within 24 hours, hives had spread to her arms and neck, and she developed sharply demarcated, erythematous macules in bilateral axillae. She went to Urgent Care the day after vaccination, was diagnosed with pityriasis rosea and prescribed topical and oral steroids, which she did not take. She was seen in a virtual appointment 5 days after the vaccination by myself her PCP, with persistent urticaria, diagnosed with an allergic reaction to the vaccine, encouraged to take the oral prednisone prescribed in Urgent Care to reduce the duration of symptoms.
headache; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) and FATIGUE (Fatigue) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced HEADACHE (headache) and FATIGUE (Fatigue). At the time of the report, HEADACHE (headache) and FATIGUE (Fatigue) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided.
Pt c/o dizziness.  Pt told to rest laying down and was given juice/crackers.  Pt return to baseline.  A&O x4.  BP 99/64, HR 84, RR 18.  Pt stable and released from the vaccination site.
Upon my incarceration in County Jail on Oct 09, 2021. On the 10th of Oct. I woke up with the left side of my face suffering from   complete paralysis, went to see medical and they diagnosed it as Bell's Palsy they also took me to the hospital to confirm on Oct.20 2021. After taking prescribed medication the symptoms have decreased but have not fully gone away.
Brain fog; headaches; memory loss; changes in mood; partial disability; aphasia; severe anxiety; depression; body aches; tinitus; can't focus; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 20May2021 as dose 2, single (Lot number: EN0173) at the age of 41 years, in right arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (DOSE 1, SINGLE; Lot Number: EN0162, Location of injection: Arm Left; Administration time: 03:30 PM), administration date: 20Apr2021, when the patient was 41-year-old, for COVID-19 Immunization. The following information was reported: BRAIN FOG (disability) with onset 10Jun2021, outcome "not recovered"; APHASIA (disability) with onset 10Jun2021, outcome "not recovered"; PAIN (disability) with onset 10Jun2021, outcome "not recovered", described as "body aches"; DISTURBANCE IN ATTENTION (disability) with onset 10Jun2021, outcome "not recovered", described as "can't focus"; MOOD ALTERED (disability) with onset 10Jun2021, outcome "not recovered", described as "changes in mood"; DEPRESSION (disability) with onset 10Jun2021, outcome "not recovered"; HEADACHE (disability) with onset 10Jun2021, outcome "not recovered", described as "headaches"; AMNESIA (disability) with onset 10Jun2021, outcome "not recovered", described as "memory loss"; DISABILITY (disability) with onset 10Jun2021, outcome "not recovered", described as "partial disability"; ANXIETY (disability) with onset 10Jun2021, outcome "not recovered", described as "severe anxiety"; TINNITUS (disability) with onset 10Jun2021, outcome "not recovered", described as "tinitus". The events "brain fog", "headaches", "memory loss", "changes in mood", "partial disability", "aphasia", "severe anxiety", "depression", "body aches", "tinitus" and "can't focus" required physician office visit and emergency room visit. Therapeutic measures were taken as a result of brain fog, headache, amnesia, mood altered, disability, aphasia, anxiety, depression, pain, tinnitus, disturbance in attention.  Clinical course: Patient had severe Brain fog, headaches, memory loss, changes in mood, partial disability as a result, aphasia, and severe anxiety beginning about 2 weeks month after the 2nd dose. Over the next year the brain fog improved slightly but the other issues remained and depression and body aches were added to the symptoms. Patient is now permanently disabled and have frequent headaches, anxiety, memory loss, brain fog, aphasia, mood issues, and can't focus. She also developed tinnitus.
Moderate aches in lower back for about 18 hours; Sore lymph nodes right side only about 16 hours; This is a spontaneous report from a non-contactable consumer, the patient. A 52-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182) via an unspecified route of administration in the left arm on 05May2021 at 09:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. The patient did not had any medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0164) via an unspecified route of administration in the left arm on 15Apr2021 at 09:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. On 05May2021 at 09:30, the patient experienced moderate aches in lower back for about 18 hours and sore lymph nodes right side only about 16 hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore lymph nodes right side only was resolved on 06May2021 at 01:30, after the duration of 16 hrs and moderate aches in lower back resolved on 06May2021 at 03:30, after the duration of 18 hrs.  No follow-up attempts are possible. No further information is expected.
Received vaccine, immediately became nauseated. No vomiting; admitted to hospital 1/5/2010 with nausea and hypercalcemia.
Rash from neck to knees/front and back torso. Antihistamine taken for rash. TYLENOL taken for soreness at injection site.
body aches after booster dose; headaches after booster dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches after booster dose) and HEADACHE (headaches after booster dose) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 103138101) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 50 microgram. In December 2021, the patient experienced PAIN (body aches after booster dose) and HEADACHE (headaches after booster dose). At the time of the report, PAIN (body aches after booster dose) and HEADACHE (headaches after booster dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided.  No treatment medications were provided.  The patient received 2 doses of the vaccine in another country.  The patient received the first dose of the vaccine on 02-May-2021 and the second dose of the vaccine on 26-May-2021.   Most recent FOLLOW-UP information incorporated above includes: On 24-Dec-2021: Follow up document received on 24-Dec-2021 contains No New Information.
After receiving my 1st shot, my shoulder pain did not go away. I waited, hoping it would get better but it did  not. I went to an orthopedic doctor and I was told it was SIRVA, injury from the shot administered in the wrong location. When I reach using my right arm, I experience great pain.   I am currently in physical therapy. I have been doing physical therapy for 4 weeks. I still am unable to reach with my right arm without pain.
Patient became lethargic and had reported syncopal-like event approximately 25 minutes after vaccine administration.    Patient was also found to be dehydrated, and malnourished; self-report from patient that he had not eaten very much in the last 2 weeks because of lack of desire to eat.
Low grade fever, body aches and swollen lymph node in armpit of arm the vaccine was injected.  The lymph node has been swollen for 2-3 days.  She has taken Tylenol and ibuprofen to decrease the swelling
She got her vaccine, everything was fine.  After she got home, about 2 hours later she started coughing nonstop coughing, which then sent her into a heavy chest, could not get her breath, could not hardly talk and struggling to breath.  She called 911 who gave her breathing treatments and took her to the ER.  They admitted her gave her oxygen, steroid, breathing treatment.  By the next morning she was doing better and she came  home yesterday afternoon.  States it was a rough go on Saturday.  She was sent home with steroids and antibiotics to make sure she had no infection, and to continue her regular home medications and inhalers.    Had four previous COVID vaccines with no difficulties.  Never had problems with flu vaccines.  Her doctor agreed that it was the COVID vaccine that sent her into respiratory issues.
Starting 12/30 evening I began feeling weird. I have had blood clots in my arms in the past and I had the same feeling.  I went to urgent care the next day. Doctor found blood clots in both my lungs and my upper right leg. They treated me to for the clots. I was in the hospital for 3 days and put on blood thinner for 3 weeks afterward. I go back to the Doctor every 2-3 days for a blood draw.
Severe myalgia, headaches, sweating, insomnia, fatigue, abnormal injection site pain, stiff neck, exacerbation of tinnitus, and confusion.   My first dose was on 03/27/2021, my second dose was on 4/21/2021, and my third and final dose was on 10/21/2021. It is slowly getting better and the side effects are starting to subside as of 10/31/2021.  I ride my road bike for exercise daily normally, I do 15 miles a day. Post shot I do not have the endurance post shot to do more than 10 miles. There is a noticeable decrease in my stamina and this is worse than the second shots side effects.  I have had numerous vaccines over the years and none of them have had the side effect profile that the Pfizer COVID shot has. I will not be taking the vaccine again.   The shot lot numbers are as follows:  03/27/2021 9267100004 04/21/2021 59267100001 10/21/2021 3203080  The doctor told me to take 500 mg of Tylenol every 4-6 hours.
Information has been received from a physician concerning male "about 45 years old" who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. Subsequently, the patient experienced "significant injection site reaction that looked like cellulitis." Subsequently, the patient recovered from significant injection site reaction after treatment with ice and NSAIDS for the pain. No further information is available.
Information has been received from a physician concerning a 11 year old male who on 13-Mar-2000 was vaccinated with the first dose of MMR, on 01-Jul-2003 was vaccinated with the second dose of MMR. Diagnose on 24-Nov-2009 revealed the patient had parotitis on both sides and the patient was afebrile. Laboratory test on 24-NOV-2009 included IgM <1:10, IgG 5.73 and serum amylase 150. On 20-DEC-2009 the patient experienced mumps. Follow-up information was received which reported that on 21-DEC-2009 the patient experienced mumps. Diagnose on 24-DEC-2009 revealed the patient had parotitis R and the patient's body temperature was 103 degree F. Additional information has been requested.
Guillian-barre syndrome from shot was down to the nerve coating and numbness.  10/20/09 Hospital records received for date of service 8/25-8/28. Discharge DX: Guillain-Barre syndrome.  Records reveal patient presented in ER with progressive ascending weakness of LE approx. 3 days after receiving vaccine.  Progressed to wheelchair bound. LP (+) isolated abnormality of elevated protein. EMG abnormal. IVIG  x3 days with dramatic improvement.  Discharged to inpatient rehab.  10/20/09 Hospital records received for date of service 8/28-9/05. Discharge DX: Acute inflammatory demyelinating polyradiculoneuropathy, neuropathic pain, hemolytic anemia secondary to IVIG. Records reveal account of inpatient rehab. Strength UE 4/5 bilaterally, LE 3/5-45. Developed neuropathic pain. Developed hemolytic anemia secondary to IVIG. No free circulating antibody. HCT stabilized at 23 and HGB at 8.8. INR and platelets stable at 463,000. Able to ambulate with supervision at discharge. To follow up with PCP and hematology.  10/20/2009 Electrophysiologic Diagnostic Consult and labs received for DOS 08/19-10/05. Diagnosis of GBS and/or AIDP confirmed. Notes patient had mild SX 1 week before admin of vaccine and SX increased thereafter.
11:25AM pt recv vax & 450PM pt c/o 1 x2cm rash on face & swelling eyelids;pt went home took med;no no c/o adverse effects;
If was influenza (quad) shot but not sure which one. Wave of dizziness within a couple minutes of vaccination, followed by a cold sensation in hands, possibly due to a blood pressure change. Sat down and waited in pharmacy for 20 minutes for symptoms to resolve. Did not report reaction to pharmacist. Felt slightly nauseated/light-headed for the next couple hours but not enough to keep from driving/errands. Was previously feeling allergy symptoms that day but no other illness.
63 year old who reports that he often feel faint when he gets shots. he received his vaccine and asked if he could immediately lie down.
Information has been received from a licensed vocational nurse concerning a 13 month old patient who on 17-MAR-2008 was vaccinated with VARIVAX (Merck). The patient was given VARIVAX (Merck) in the thigh (right side). Eight days after vaccination the patient presented red & swollen thigh (right side). The patient sought medical attention and came to see physician. As the time of repot the patient was improving. Additional information has been requested.
ABOUT 3 TO 5 MINUTES AFTER TAKING THE VACCINE, PATIENT STARTING FEELING DIZZING AND SWEETING PROFUSELY AND HAND TIGHTENING. PATIENT ALERT AND BREATHING AT THE TIME
Extreme headache, nausea, diarrhea, body aches, muscle weakness, extreme fatige, fever, chills. Pain, swelling and hardening at the injection site. Swelling at injection site larger than a golf ball.
I got my periods regularly on December 24th , 2021 and ended within 4 days which is my ideal period length. But now in my ovulation phase I have been seeing spotting and heavy flow from January 5th, 2022 till today and not sure how long it will continue. I am not totally sure if it is related to the booster shot but I generally never see spotting and have been having consistent periods of 28 days average for a long time
Hep B given at 08:30 a.m. at a school clinic.  On 10-18-02 the school nurse reported a 3 inch enduration at the site with small bumps & c/o itching.  Child saw Dr. 10/18 and Allegra was prescribed for assumed allergic response at the site.  Child was afebrile. On 10/21 Mother reports redness is resolving small bumps still present with some itchiness
No adverse effects reported; A HCP called to report that a improperly stored dose of VARIVAX was administered to a patient; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history and drug reactions/allergies were not reported. Concomitant medication included sterile diluent (manufacturer unknown).  On 12-AUG-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 ml/once, lot #W003820, expiration date: 02-FEB-2024, (strength, and route of administration were not provided) administered for prophylaxis (product storage error). No adverse effects reported.   The administered dose of the vaccine experienced a temperature excursion in 6 degrees Fahrenheit (F) up to 14 F for 14 hours 10 minutes, and in 14 F up to 46 F (16.7F) for 5 hours 40 minutes. There was no previous temperature excursion.   This is one of four cases received from the same reporter.; Sender's Comments:  US-009507513-2208USA006030: US-009507513-2208USA006265: US-009507513-2208USA006344:
Hurt to raise his arm the day after getting vaccine; This is a spontaneous report from a contactable consumer (patient). A 40-year-old male patient received BNT162b2 (Pfizer BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number and Expiration date was not reported) via an unspecified route of administration on an unspecified date dose 2, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the day after getting vaccine, patient hurt to raise his arm. The outcome of the event was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Burning feeling from injection site into right chest and breast immediately. Nausea a couple hours later. Increased pain injection site. Throughout  the day. Approximately 8 hours later, severe body aches and pain throughout entire body. Chills. 24 hours after shot, increased severe body aches and pain. Mild Headache. Chills. Overall severe flu like symptoms, weakness in entire body.
This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's medical history, drug reactions/allergies and concurrent conditions were not reported. On 08-NOV-2016, the patient was vaccinated with a dose of PROQUAD lot number M017336, expiration date: 05-OCT-2017 (strengh, dose, frequency and route were not reported) for prophylaxis, which was improperly stored at 19 degrees Fahrenheit for 12 hours. Previous temperature excursions were reported as follows:  -From 01-AUG-2016 to 05-AUG-2016, temperature was between 6 degrees Fahrenheit to 17 degrees Fahrenheit for 120 hours. -From 08-AUG-2016 to 12-AUG-2016, temperature was between 6 degrees Fahrenheit to 11 degrees Fahrenheit for 120 hours. -On 25-AUG-2016, temperature was at 14 degrees Fahrenheit for 9 hours. -On 29-AUG-2016, temperature was at 6 degrees Fahrenheit for 8 hours. -On 02-SEP-2016, temperature was at 6 degrees Fahrenheit for 8 hours. -From 07-SEP-2016 to 09-SEP-2016, temperature was at 7 degrees Fahrenheit for 48 hours. -On 16-SEP-2016, temperature was at 5 degrees Fahrenheit for 16 hours. -On 19-SEP-2016, temperature was at 7 degrees Fahrenheit for 24 hours. -On 27-SEP-2016, temperature was at 7 degrees Fahrenheit for 24 hours. -From 30-SEP-2016 to 03-OCT-2016, temperature was at 6 degrees Fahrenheit for 84 hours. -From 06-OCT-2016 to 07-OCT-2016, temperature was between 7 degrees Fahrenheit to 10 degrees Fahrenheit for 36 hours. -From 10-OCT-2016 to 12-OCT-2016, temperature was between 6 degrees Fahrenheit to 9 degrees Fahrenheit for 48 hours. -On 25-OCT-2016, temperature was at 6 degrees Fahrenheit for 24 hours. -From 08-NOV-2016 to 09-NOV-2016, temperature was at 19 degrees Fahrenheit for 32 hours. Additionally, no adverse symptoms were reported and no product quality complaint was involved. Follow up information has been received from the medical assistant on 02-FEB-2017, indicating the patient was a White 4 year-old child with a concurrent condition of functioning heart murmur. The patient was vaccinated with the first dose of PROQUAD on 08-NOV-2016 at 14:00 hours, subcutaneously, on the left deltoid. Additional information is not expected, as the requested information has been obtained.
Bell's palsy/Facial droop; facial numbness; This is a spontaneous report from a contactable other health care professional. A 68-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 intramuscular, administered in Arm Left on 04Mar2021 (at the age of 68-years-old) (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. Medical history included diabetes, Blood pressure, cholesterol. Concomitant medications included insulin glargine (LANTUS) taken for diabetes mellitus; insulin lispro (HUMALOG) taken for diabetes mellitus; amlodipine besilate (NORVASC) taken for blood pressure abnormal; lisinopril (LISINOPRIL) taken for blood pressure abnormal; atorvastatin (LIPITOR [ATORVASTATIN]) taken for blood cholesterol; start and stop dates were not reported. On 22Mar2021, the patient experienced Bell's palsy/facial droop, and facial numbness. The outcome of the events was not recovered. The patient received treatment for the events: Nurse Practitioner stated, "She was given by the emergency room. She was treated with Prednisone. 20mg, tablet, 3 tablet one time in a day, oral. Bell's palsy. She was also given Valtrex. 1gm, oral, tablet, 3 times a day."  Information about lot/batch number has been requested.; Sender's Comments: Based on the temporal association, a possible contributory role of bnt162b2 to the development of Bell's palsy/facial droop cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.